Iberdomide

SUSPENDED · PHASE1, PHASE2 · Recurrent Multiple Myeloma, Refractory Multiple Myeloma

Enrollment to Dose Level 1 cohort has been met

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.